Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007-2012

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2017 Sep 21

PMID 28930014

Citations 26

Authors

Emily Henkle

Katrina Hedberg

Sean D Schafer

Kevin L Winthrop

Affiliations

Soon will be listed here.

Abstract

Limited data are available describing extrapulmonary nontuberculous mycobacteria (NTM) infections in the general population. We describe results from statewide population-based laboratory surveillance in Oregon, USA, during 2007-2012. We defined a case of extrapulmonary NTM infection as >1 isolate from skin/soft tissue, disseminated sites, lymph node, joint, or other sites. The annual incidence of extrapulmonary NTM infection (other than Mycobacterium gordonae) was stable, averaging 1.5 cases/100,000 population. Median age of the 334 patients was 51 years, and 53% of patients were female. Half of cases were caused by M. avium complex, but rapid-growing NTM species accounted for one third of cases. Most extrapulmonary NTM infections are skin/soft tissue. Compared with pulmonary NTM infection, more extrapulmonary infections are caused by rapid-growing NTM species. the designation of NTM as a reportable disease in Oregon in 2014 will result in better detection of changes in the incidence and patterns of disease in the future.

Citing Articles

Yield of routine mycobacterial culture of osteoarticular specimens in a tertiary orthopaedic hospital in England, 2017-2022.

Yates T, Vahesan O, Warren S, Scobie A J Bone Jt Infect. 2024; 9(5):217-223.

PMID: 39539731 PMC: 11554712. DOI: 10.5194/jbji-9-217-2024.

Case report: -induced lymph node infection in a patient with chronic myeloproliferative neoplasm misdiagnosed as tuberculous lymphadenitis.

Sun Y, Zhang C, Lu B, Chen J, Pan X Front Public Health. 2024; 12:1387722.

PMID: 39381756 PMC: 11458419. DOI: 10.3389/fpubh.2024.1387722.

Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease.

Lin W, Tang F, Liu S Am J Transl Res. 2024; 16(8):4208-4215.

PMID: 39262756 PMC: 11384362. DOI: 10.62347/HHRH8076.

Investigating cutaneous tuberculosis and nontuberculous mycobacterial infections a Department of Dermatology, Beijing, China: a comprehensive clinicopathological analysis.

Wang X, Jia Q, Li J, Zheng H Front Cell Infect Microbiol. 2024; 14:1451602.

PMID: 39247053 PMC: 11377312. DOI: 10.3389/fcimb.2024.1451602.

In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria.

Imperiale B, Mancino M, Moyano R, de la Barrera S, Morcillo N J Antibiot (Tokyo). 2024; 77(5):306-314.

PMID: 38438500 DOI: 10.1038/s41429-024-00709-3.

References

Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

Lyman M, Grigg C, Bicking Kinsey C, Keckler M, Moulton-Meissner H, Cooper E . Invasive Nontuberculous Mycobacterial Infections among Cardiothoracic Surgical Patients Exposed to Heater-Cooler Devices. Emerg Infect Dis. 2017; 23(5):796-805. PMC: 5403026. DOI: 10.3201/eid2305.161899. View

Schnabel D, Esposito D, Gaines J, Ridpath A, Barry M, Feldman K . Multistate US Outbreak of Rapidly Growing Mycobacterial Infections Associated with Medical Tourism to the Dominican Republic, 2013-2014(1). Emerg Infect Dis. 2016; 22(8):1340-1347. PMC: 4982176. DOI: 10.3201/eid2208.151938. View

Zimmermann P, Tebruegge M, Curtis N, Ritz N . The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis. J Infect. 2015; 71(1):9-18. DOI: 10.1016/j.jinf.2015.02.010. View

Winthrop K, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M . Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010; 182(7):977-82. DOI: 10.1164/rccm.201003-0503OC. View

Smith G, Ghio A, Stout J, Messier K, Hudgens E, Murphy M . Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect. 2016; 72(6):678-686. DOI: 10.1016/j.jinf.2016.03.008. View

Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop K . Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015; 12(5):642-7. PMC: 4418336. DOI: 10.1513/AnnalsATS.201412-559OC. View

Winthrop K, Abrams M, Yakrus M, Schwartz I, Ely J, Gillies D . An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med. 2002; 346(18):1366-71. DOI: 10.1056/NEJMoa012643. View

Varley C, Ku J, Henkle E, Schafer S, Winthrop K . Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012. Emerg Infect Dis. 2017; 23(3):533-535. PMC: 5382736. DOI: 10.3201/eid2303.161708. View

10.

Maureen Cassidy P, Hedberg K, Saulson A, McNelly E, Winthrop K . Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009; 49(12):e124-9. DOI: 10.1086/648443. View

11.

Marras T, Mendelson D, Marchand-Austin A, May K, Jamieson F . Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013; 19(11):1889-91. PMC: 3837646. DOI: 10.3201/eid1911.130737. View

12.

Prevots D, Shaw P, Strickland D, Jackson L, Raebel M, Blosky M . Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010; 182(7):970-6. PMC: 2970866. DOI: 10.1164/rccm.201002-0310OC. View

13.

Henkle E, Winthrop K . Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015; 36(1):91-9. PMC: 4710582. DOI: 10.1016/j.ccm.2014.11.002. View